Becton Dickinson

Coronavirus (COVID-19) Update: FDA Issued Emergency Use Authorization for Point of Care Antigen Test

Retrieved on: 
Monday, July 6, 2020
Medicine, Immunologic tests, Health, Emergency Use Authorization, Food and Drug Administration, Clinical medicine, Becton Dickinson, ELISA, Severe acute respiratory syndrome

SILVER SPRING, Md., July 6, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for a COVID-19 antigen diagnostic test, the BD (Becton Dickinson) Veritor System for Rapid Detection of SARS-CoV-2.

Key Points: 
  • SILVER SPRING, Md., July 6, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) for a COVID-19 antigen diagnostic test, the BD (Becton Dickinson) Veritor System for Rapid Detection of SARS-CoV-2.
  • This is the second antigen test the FDA has authorized for the detection of SARS-CoV-2 antigens.
  • Emergency use of this test is limited to authorized laboratories using the BD Veritor Plus Analyzer Instrument.
  • Antigen tests play an important role in the overall response against COVID-19, including as a point-of-care test that can potentially scale up to test millions of Americans quickly," said FDA Commissioner Stephen M. Hahn, M.D.

CME America Announces a Follow-Up on the Voluntary Recall of BodyGuard® Infusion System Administration Sets

Retrieved on: 
Friday, July 3, 2020
Life sciences, Medical technology, Medicine, Infusion set, Infusion pump, Becton Dickinson, Recall, Precision and recall

GOLDEN, Colo., July 3, 2020 /PRNewswire/ -- CME America, a wholly owned subsidiary of BD (Becton, Dickinson and Company), announced a voluntary recall for all CME America BodyGuard Infusion System Administration Sets (infusion sets)used with the company's BodyGuard infusion pumpsthat were distributed beginning May 2016 (see complete impacted product list below).

Key Points: 
  • GOLDEN, Colo., July 3, 2020 /PRNewswire/ -- CME America, a wholly owned subsidiary of BD (Becton, Dickinson and Company), announced a voluntary recall for all CME America BodyGuard Infusion System Administration Sets (infusion sets)used with the company's BodyGuard infusion pumpsthat were distributed beginning May 2016 (see complete impacted product list below).
  • As part of CME America's commitment to quality, following the previously announced recall (April 27, 2020) of the BodyGuard Infusion Pump Systems, the company conducted additional flow-rate accuracy testing.
  • This testing revealed that some infusion sets do not meet the 5% delivery accuracy for the system or the 13% accuracy identified in the earlier recall notification ( https://www.bd.com/en-us/support/recall-notifications/recall-notificatio... ).
  • Based on those test results CME America is providing additional information and customer actions regarding its previous recall to include all infusion sets used with the BodyGuard infusion pump distributed beginning May 2016.

BD Announces Live Webcast Of Third Fiscal Quarter Earnings Conference Call

Retrieved on: 
Thursday, July 2, 2020
Becton Dickinson, Franklin Lakes, New Jersey, BDX, Becton, BD, Dickinson

FRANKLIN LAKES, N.J., July 2, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2020 earnings conference call on Thursday, August 6, 2020, at 8:00 a.m. (ET).

Key Points: 
  • FRANKLIN LAKES, N.J., July 2, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its third fiscal quarter 2020 earnings conference call on Thursday, August 6, 2020, at 8:00 a.m. (ET).
  • BD will issue a press release detailing the quarter's earnings earlier that morning.
  • The webcast of the conference call, along with related slides, will be accessible through BD's website at www.bd.com/investors and will be available for replay through Thursday, August 13, 2020.
  • By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Surgical Scalpel Market 2020-2024 | Increase in Volume of Surgeries to Boost Growth | Technavio

Retrieved on: 
Wednesday, July 1, 2020
Surgery, Health, Medical Supplies, Surgical instruments, Scalpel, B. Braun Melsungen, Becton Dickinson, Life sciences, Biotechnology, Medicine

Our surgical scalpel market report covers the following areas:

Key Points: 
  • Our surgical scalpel market report covers the following areas:
    This study identifies growing demand for disposable surgical scalpels as one of the prime reasons driving the surgical scalpel market growth during the next few years.
  • We provide a detailed analysis of vendors operating in the surgical scalpel market, including some of the vendors such as Aspen Surgical Products Inc., B. Braun Melsungen AG, Becton, Dickinson and Co., Cincinnati Surgical Co. Inc., Danaher Corp., Kai Corp., Merit Medical Systems Inc., pfm medical ag, Swann Morton Ltd., and Troge Medical GmbH.
  • Backed with competitive intelligence and benchmarking, our research reports on the surgical scalpel market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

Global Market Outlook for the Coronavirus Diagnostics Market to 2027

Retrieved on: 
Friday, June 19, 2020
Companies, Industries, Life sciences, Medical software, Qiagen, Ortho Clinical Diagnostics, PerkinElmer, Coronavirus, BioMérieux, Becton Dickinson, Beckman Coulter, Bio-Rad Laboratories

DUBLIN, June 19, 2020 /PRNewswire/ -- The "Coronavirus Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, June 19, 2020 /PRNewswire/ -- The "Coronavirus Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Coronavirus Diagnostics market accounted for $4.64 billion in 2018 and is expected to reach $8.82 billion by 2027 growing at a CAGR of 7.4% during the forecast period.
  • Some of the key players profiled in the Coronavirus Diagnostics Market include Abbott, Beckman Coulter, Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics.
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
    Company profiling with detailed strategies, financials, and recent developments

2020 Coronavirus Diagnostics Market Analysis by Type, Time Duration, Application, End-User and Geography - ResearchAndMarkets.com

Retrieved on: 
Friday, June 12, 2020
Infectious diseases, Biotechnology, Health, Companies, Industries, Life sciences, Medical software, Qiagen, Ortho Clinical Diagnostics, PerkinElmer, Coronavirus, BioMérieux, Becton Dickinson, Beckman Coulter, Bio-Rad Laboratories

The "Coronavirus Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Coronavirus Diagnostics - Global Market Outlook (2018-2027)" report has been added to ResearchAndMarkets.com's offering.
  • The Global Coronavirus Diagnostics market accounted for $4.64 billion in 2018 and is expected to reach $8.82 billion by 2027 growing at a CAGR of 7.4% during the forecast period.
  • Some of the key players profiled in the Coronavirus Diagnostics Market include Abbott, Beckman Coulter, Becton, Dickinson and Company, bioMerieux, Bio-Rad Laboratories, GSK Biologicals, Hologic, Lonza, Ortho-Clinical Diagnostics, PerkinElmer, Qiagen and Roche Diagnostics.
  • Covers Market data for the years 2017, 2018, 2019, 2023 and 2027
    Company profiling with detailed strategies, financials, and recent developments

Global Cell Sorting Market 2019-2023 | Growing Applications in Cancer Research to Boost Growth | Technavio

Retrieved on: 
Monday, June 1, 2020
Biotechnology, Health, Oncology, Stem cells, Branches of biology, Articles, Biology, Benchmarking, Strategic management, Marketing strategy, Cell sorting, Market research, Becton Dickinson, Marketplace, Bio-Rad Laboratories

Our cell sorting market report covers the following areas:

Key Points: 
  • Our cell sorting market report covers the following areas:
    This study identifies technological advances as one of the prime reasons driving the cell sorting market growth during the next few years.
  • We provide a detailed analysis of around 25 vendors operating in the Cell Sorting Market, including some of the vendors such as Becton, Dickinson, and Co., Bio-Rad Laboratories Inc., Cytonome/St.
  • Backed with competitive intelligence and benchmarking, our research reports on the Cell Sorting Market are designed to provide entry support, customer profile and M&As as well as go-to-market strategy support.
  • Register for a free trial today and gain instant access to 17,000+ market research reports.

BD to Present at Investor Conferences

Retrieved on: 
Monday, June 1, 2020
Becton Dickinson, Franklin Lakes, New Jersey, BDX, BD, Becton, Dickinson

FRANKLIN LAKES, N.J., June 1, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor conferences:

Key Points: 
  • FRANKLIN LAKES, N.J., June 1, 2020 /PRNewswire/ --BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor conferences:
    Live webcasts of BD's presentations can be accessed on the BD corporate website at www.bd.com/investors .
  • BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care.
  • BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues.
  • By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

BD to Present at Jefferies Virtual Healthcare Conference

Retrieved on: 
Tuesday, May 26, 2020
Becton Dickinson, Franklin Lakes, New Jersey, BDX, Becton, BD, Dickinson

FRANKLIN LAKES, N.J., May 26, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 11:00 a.m.

Key Points: 
  • FRANKLIN LAKES, N.J., May 26, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020, at 11:00 a.m.
  • A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors and will be available for replay through Thursday, June 11, 2020.
  • BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues.
  • By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.

Coronavirus Test Kits Market in North America 2020: Analyis of Key Players Abbott Laboratories, Becton Dickinson and Co., Hologic Inc. and Thermo Fisher Scientific Inc.

Retrieved on: 
Tuesday, May 26, 2020
Companies, Life sciences, Industries, Coronaviridae, Danaher Corporation, Thermo Fisher Scientific, Hoffmann-La Roche, LabCorp, Coronavirus, Becton Dickinson

The coronavirus test kits market in North America covers the following areas:

Key Points: 
  • The coronavirus test kits market in North America covers the following areas:
    Coronavirus test kits market in North America industry analysis.
  • This robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading coronavirus test kits market in North America vendors that include Abbott Laboratories, Becton, Dickinson and Co., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann-La Roche Ltd., GenMark Diagnostics Inc., Hologic Inc., Laboratory Corp. of America Holdings, Quidel Corp., and Thermo Fisher Scientific Inc. Also, the coronavirus test kits market in North America analysis report includes information on upcoming trends and challenges that will influence market growth.
  • The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
  • The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.